About IAC
A-Z Index
Immunization Action Coalition

Vaccine-Related Journal Articles

Vaccine Concerns: Measles, Mumps, Rubella (MMR)

Recent articles
Measles 2003
Specialist Vaccination Advice and Pockets of Resistance to MMR Vaccination: Lessons From An Outbreak of Measles
Authors: Morgan OW, Meltzer M, Muir D, et al
Source: Commun Dis Public Health, December 2003, Vol. 6(4):330-333
Communicating Science to the Public: MMR Vaccine and Autism
Authors: Offit PA, Coffin SE
Source: Vaccine, December 8, 2003, Vol. 22(1):1-6
Measles Epidemic Attributed to Inadequate Vaccination Coverage --- Campania, Italy, 2002
Source: MMWR, October 31, 2003, Vol. 52(43):1044-1047
The Cost of Measles in Industrialised Countries
Authors: Carabin H, Edmunds WJ, Gyldmark M, et al
Source: Vaccine, October 1, 2003, Vol. 21(27-28):4167-77
Measles Epidemic--Majuro Atoll, Republic of the Marshall Islands, July 13-September 13, 2003
Source: MMWR, September 19, 2003, Vol. 52(37):888-9
Unintended Events Following Immunization with MMR: a Systematic Review
Authors: Jefferson T, Price D, Demicheli V, et al
Source: Vaccine, Sept. 8, 2003, Vol. 21(25-26):3954-3960
Survival of Previously Measles-vaccinated and Measles-unvaccinated Children in an Emergency Situation: An Unplanned Study
Authors: Aaby P, Garly ML, Bale C, et al
Source: The Pediatric Infectious Disease Journal, Sept. 2003, Vol.22(9):798-805
Prevalence of Autism and Parentally Reported Triggers in a North East London Population
Authors: Lingam R, Simmons A, Andrews N, et al
Source: Archives of Disease in Childhood, August 2003, Vol. 88(8):666-670
Seroconversion After Measles Vaccination at Nine and Fifteen Months of Age
Authors: Isik N, Uzel N, Gokcay G, et al
Source: The Pediatric Infectious Disease Journal, August 2003, Vol. 22(8):691-695
Measles-Mumps-Rubella Vaccine and the Development of Autism
Author: Miller E
Source: Seminars in Pediatric Infectious Diseases, July 2003, Vol. 14(3):199-206
WHO European Region's Strategy for Elimination of Measles and Congenital Rubella Infection
Authors: Hanon FX, Spika JJ, Wassilak SS, et al
Source: Euro Surveillance, June 2003, Vol. 8(6):129-138
Measles in Europe in 2001-2002
Authors: Muscat M, Glismann S, Bang H
Source: Euro Surveillance, June 2003, Vol. 8(6):123-129
Update: Global Measles Control and Mortality Reduction - Worldwide, 1991-2001
Source: MMWR, May 23, 2003, Vol. 52(20):471-475
Progress in Reducing Global Measles Death
Source: Weekly Epidemiological Report, May 23, 2003, Vol. 78(21):184-7
Progress in Accelerated Measles Control in the People's Republic of China
Authors: Lixia W, Guang Z, Lee LA, et al
Source: Journal of Infectious Diseases, May 15, 2003, Vol. 187(Suppl 1):S252-257
Click here for abstract
Accelerated Measles Control in the Western Pacific Region
Authors: McFarland JW, Mansoor OD, Yang B
Source: Journal of Infectious Diseases, May 15, 2003, Vol. 187(Suppl 1):S246-251
Measles and Rubella in the World Health Organization European Region: Diversity Creates Challenges
Authors: Spika JS, Wassilak S, Pebody R, et al
Source: J Infect Dis, May 15, 2003, Vol. 187(Suppl 1):S191-197
The Challenge of Achieving Measles Elimination in the Eastern Mediterranean Region by 2010
Authors: Gaafar T, Moshni E, Lievano F
Source: J Infect Dis, May 15, 2003, Vol. 187(Suppl 1):S164-171
Progress Toward Measles Eradication in the Region of the Americas
Authors: De Quadros CA, Izurieta H, Carrasco P, et al
Source: J Infect Dis, May 15, 2003, Vol. 187(Suppl 1):S102-110
Future Savings from Measles Eradication in Industrialized Countries
Authors: Carabin H, Edmunds WJ
Source: J Infect Dis, May 15, 2003, Vol. 187(Suppl 1):S29-35
Experience in Global Measles Control, 1990-2001
Authors: Henao-Restrepo AM, Strebel P, John Hoekstra E, et al
Source: J Infect Dis, May 15, 2003, Vol. 187(Suppl 1):S15-21
The Global Burden of Measles in the Year 2000--A Model That Uses Country-Specific Indicators
Authors: Stein CE, Birmingham M, Kurian M, et al
Source: J Infect Dis, May 15, 2003, Vol. 187(Suppl 1):S8-14
Impact of Alternative Approaches to Accelerated Measles Control: Experience in the African Region, 1996-2002
Authors: Otten MW Jr, Okwo-Bele JM, Kezaala R, et al
Source: J Infect Dis, May 15, 2003, Vol. 187(Suppl 1):S36-43
Global Measles Mortality Reduction and Regional Elimination: A Status Report
Source: Journal of Infectious Diseases, May 15, 2003, Vol. 187(Suppl 1)
This supplemental issue of The Journal of Infectious Diseases is devoted to measles. Sections include: Public Health Importance of Measles, Regional and Country Experiences with Different Measles Control Strategies (with information on African, American, Eastern Mediterranean, European, Southeast Asian, and Western Pacific regions), and Epidemiologic and Laboratory Aspects of Program Monitoring.
The Unfinished Measles Immunization Agenda
Authors: Strebel P, Cochi S, Grabowsky M, et al
Source: Journal of Infectious Diseases, May 15, 2003, Vol. 187(Suppl 1):S1-7
Monitoring Vaccine Safety During Measles Mass Immunization Campaigns: Clinical and Programmatic Issues
Authors: Pless RP, Bentsi-Enchill AD, Duclos P
Source: Journal of Infectious Diseases, May 15, 2003, Vol. 187(Suppl 1):S291-8
Measles Vaccination Improves the Equity of Health Outcomes: Evidence from Bangladesh
Authors: Bishaia D, Koenig M, Khan MA
Source: Health Econ, May 2003, Vol. 12(5):415-419
Nationwide Measles Vaccination Campaign for Children Aged 6 Months-12 Years--Afghanistan, 2002
Source: MMWR, April 25, 2003, Vol. 52(16):363-366
Measles: Not Just Another Viral Exanthem
Authors: Duke T, Mgone CS
Source: Lancet, March 1, 2003, Vol. 361(9359):763-773
Autism--Another Topic Often Lacking Facts When Discussed within the Chiropractic Profession
Author: Ferrance RJ
Source: Journal of the Canadian Chiropractic Association, March 2003, Vol. 47(1):4-7
Measles: The Disease and Its Prevention (Review)
Author: Bedford H
Source: Nursing Standard, Feb. 26-Mar. 4, 2003, Vol. 17(24):46-52
The Survival Benefit of Measles Immunization May Not Be Explained Entirely by the Prevention of Measles Disease: A Community Study from Rural Bangladesh
Authors: Aaby P, Bhuiya A, Nahar L, Knudsen K, De Francisco A, Strong M
Source: International Journal of Epidemiology, February 2003, Vol. 32(1):106-116
back to top
Measles 2002
Measles Outbreak Among Internationally Adopted Children Arriving in the United States, February--March 2001
Source: MMWR, December 13, 2002, Vol. 51(49):1115-1116
Accuracy of Routine Data on MMR Vaccination Coverage and Validity of Parental Recall of Vaccination
Authors: Lyratzopoulos G, Aston R, Bailey K, et al
Source: Commun Dis Public Health, December 2002, Vol. 5(4):305-310
Hospitalizations During a Measles Epidemic in the Netherlands, 1999 to 2000
Authors: Van Den Hof S, Smit C, Van Steenbergen JE, et al
Source: Pediatr Infect Dis J, December 2002, Vol. 21(12):1146-50
A Population-Based Study of Measles, Mumps, and Rubella Vaccination and Autism
Authors: Madsen KM, Hviid A, Vestergaard M, et al
Source: New England Journal of Medicine, November 7, 2002, Vol. 347(19):1477-1482
Neurologic Disorders After Measles-Mumps-Rubella Vaccination
Authors: Makela A, Nuorti JP, Peltola H
Source: Pediatrics, November 2002, Vol. 110(5):957-963
Timeliness of Childhood Immunizations
Authors: Luman ET, McCauley MM, Stokley S, Chu SY, Pickering LK
Source: Pediatrics, November 2002, Vol. 110(5):935-9
African-American Children are at Risk of a Measles Outbreak in an Inner-City Community of Chicago, 2000
Authors: Rosenthal J, Raymond D, Morita J, et al
Source: American Journal of Preventive Medicine, October 2002, Vol. 23(3):195
Consequences of Delayed Measles Vaccination in Germany
Authors: Siedler A, Hermann M, Schmitt HJ, Von Kries R
Source: Pediatr Infect Dis J, September 2002, Vol. 21(9):826-830
Outbreak of Measles--Venezuela and Colombia, 2001-2002
Source: MMWR, August 30, 2002, Vol. 51(34):757-760
Seroprevalence of Measles, Rubella, and Varicella in Refugees
Authors: Barnett ED, Christiansen D, Figueira M
Source: Clinical Infectious Diseases, August 15, 2002, Vol. 35:403-408
On the 2002 Measles Vaccination Furore in the UK
Author: Spier RE
Source: Vaccine, July 26, 2002, Vol. 20(23-24):2845-7
Notice to Readers: Resumption of Routine Schedule for Diphtheria and Tetanus Toxoids and Acellular Pertussis Vaccine and for Measles, Mumps, and Rubella Vaccine
Source: MMWR, July 12, 2002, Vol. 51(27):598-9
WHO-UNICEF Joint Statement on Strategies to Reduce Measles Mortality Worldwide
Source: Weekly Epidemiological Record, July 5, 2002, Vol. 77(27):224-8
MMR Vaccination and Autism: Is There a Link?
Authors: DeStefano F, Thompson WW
Source: Expert Opinion on Drug Safety, July 2002, Vol. 1(2):115-120
Suboptimal Measles-Mumps-Rubella Vaccination Coverage Facilitates an Imported Measles Outbreak in Ireland
Authors: Coughlan S, Connell J, Cohen B, Jin L, Hall WW
Source: Clinical Infectious Diseases, July 2002, Vol. 35(1):84-6
Susceptibility of Healthcare Workers to Measles, Mumps Rubella and Varicella
Authors: Fedeli U, Zanetti C, Saia B
Source: Journal of Hospital Infection, June 28, 2002, Vol. 51(2): 133-5
Vaccination with Measles, Mumps, and Rubella Vaccine and Varicella Vaccine: Safety, Tolerability, Immunogenicity, Persistence of Antibody and Duration of Protection Against Varicella in Healthy Children
Authors: Shinefield HR, Black SB, Staehle BO, et al
Source: Pediatric Infectious Disease Journal, June 2002, Vol. 21(6):555-61
Effect of Differing Immunization Policies on Circulating Measles Antibody Levels in US and Canadian Children
Authors: Poland GA, Jacobson RM, Vierkant RA, et al
Source: Mayo Clinic Proceedings, May 2002, Vol. 77:446-452
Time to Look Beyond MMR in Autism Research
Source: The Lancet, February 23, 2002, Vol. 359(9307):637
Measles, Mumps, and Rubella Vaccination and Bowel Problems or Developmental Regression in Children with Autism: Population Study
Authors: Taylor B, Miller E, Lingam R, Andrews N, Simmons A, Stowe J
Source: British Medical Journal, February 16, 2002, Vol. 324(7334):393-6
Measles--United States, 2000
Source: MMWR, February 15, 2002, Vol. 51(6):120-3
Measles, Mumps and Rubella Vaccine, Autism and Inflammatory Bowel Disease: Advising Concerned Parents
Authors: Elliman DA, Bedford HE
Source: Paediatric Drugs 2002, Vol. 4(10):631-5
back to top
Measles 2001-1996

Notice to Readers: Revised ACIP Recommendation for Avoiding Pregnancy After Receiving a Rubella-Containing Vaccine
Source: MMWR, December 14, 2001, Vol. 50(49):1117

Simultaneous Administration of Varicella Vaccine and Other Recommended Childhood Vaccines--United States, 1995—1999
Source: MMWR, November 20, 2001, Vol. 50:1058-1061
Safety of Combination Vaccines: Perception Versus Reality
Author: Halsey NA
Source: Pediatric Infectious Disease Journal, November 2001, Vol. 20(11 Suppl):S40-4
No Evidence for a New Variant of Measles-Mumps-Rubella-Induced Autism
Authors: Fombonne E, Chakrabarti S
Source: Pediatrics, October 2001, Vol. 108(4):E58
Measles Outbreak in a Community with Very Low Vaccine Coverage, the Netherlands
Authors: van den Hof S, Meffre CMA, Conyn-van Spaendonck MAE, Woonink F, de Melker HE, van Binnendijk RS
Source: Emerging Infectious Diseases, June 2001 Supplement, Vol. 7(3)
Measles-Mumps-Rubella Vaccine and Autistic Spectrum Disorder: Report From the New Challenges in Childhood Immunizations Conference Convened in Oak Brook, Illinois, June 12-13, 2000
Authors: Halsey NA, Hyman SL, and the Conference Writing Panel
Source: Pediatrics, May 2001, Vol. 107(5):e84
Measles-Mumps-Rubella and Other Measles-Containing Vaccines Do Not Increase the Risk for Inflammatory Bowel Disease
Authors: Davis RL, Kramarz P, Bohlke K, et al
Source: Archives of Pediatric and Adolescent Medicine, March 2001, Vol.155(3):354-359
Time Trends in Autism and in MMR Immunization Coverage in California
Authors: Dales L, Hammer SJ, Smith NJ
Source: Journal of American Medical Association, March 7, 2001, Vol. 285(9):1183-5
Mumps, Measles, and Rubella Vaccine and the Incidence of Autism Recorded by General Practitioners: a Time Trend Analysis
Authors: Kaye JA, Melero-Montes M, Jick H
Source: British Medical Journal, February 24, 2001, Vol. 322:460-463
National Serologic Survey of Measles Immunity Among Persons 6 Years of Age or Older, 1988-1994
Authors: Hutchins SS, Redd SC, Schrag S, Kriszon-Moran D, Wooten K, McQuillan GM, Bellini W, Meyer PA, Hadler S
Source: National Immunization Program, Centers for Disease Control and Prevention, January 24, 2001
Immunization Safety Review: Measles-Mumps-Rubella Vaccine and Autism
Source: Institute of Medicine’s Immunization Safety Review Committee, 2001
Serious Adverse Events After Measles-Mumps-Rubella Vaccination During a Fourteen-Year Prospective Follow-Up
Authors: Patja A, Davidkin I, Kurki T, Kallio MJT, Valle M, Peltola H
Source: Pediatric Infectious Diseases Journal, December 2000, Vol. 19(12):1127-1134
Recommendations from Meeting on Strategies for Improving Global Measles Control, May 11-12, 2000
Source: MMWR, December 15, 2000, Vol. 49(49):1116-8
Measles Eradication: Is It in Our Future?
Authors: Orenstein WA, Strebel PM, Papania M, Sutter RW, Bellini WJ, Cochi SL
Source: American Journal of Public Health, October 2000, Vol. 90(10):1521-5
Measles History and Atopic Diseases: A Population-Based Cross-Sectional Study
Authors: Paunio M, Heinonen OP, Virtanen M, Leinikki P, Patja A, Peltola H
Source: JAMA, January 19, 2000, Vol. 283(3):343-6
Measles Epidemic in Romania, 1996-1998: Assessment of Vaccine Effectiveness by Case-Control and Cohort Studies
Authors: Hennessey KA, Ion-Nedelcu N, Craciun MD, Toma F, Wattigney W, Strebel PM
Source: American Journal of Epidemiology, December 1, 1999, Vol. 150(11):1250-7
Increased Susceptibility to Measles in Infants in the United States
Authors: Papania M, Baughman AL, Lee S, et al
Source: Pediatrics, November 1999, Vol. 104(5):e59
Measles Among Adults, United States, 1985-1995
Authors: Miller M, Williams WW, Red SC
Source: American Journal of Preventive Medicine, August 1999, Vol. 17(2):114-9
Increased Protections During a Measles Outbreak of Children Previously Vaccinated with a Second Dose of Measles-Mumps-Rubella Vaccine
Authors: Vitek CR, Aduddell M, Brinton MJ, Hoffman RE, Redd SC
Source: Pediatric Infectious Diseases Journal, July 1999, Vol. 18(7):620-3
Combination Vaccines for Childhood Immunization
Source: MMWR, May 14, 1999, Vol. 48(RR05):1-15
Timing and Effectiveness of Requirements for a Second Dose of Measles Vaccine
Authors: Thomas A, Xu D, Wooten K, Morrow B, Redd S
Source: Pediatric Infectious Diseases Journal, March 1999, Vol. 18(3):266-270
Transmission of Measles Among a Highly Vaccinated School Population–Anchorage, Alaska, 1998
Source: MMWR, January 8, 1999, Vol. 47(51):1109-1111
A Model to Estimate the Potential Economic Benefits of Measles Eradication for the United States
Authors: Miller MA, Redd S, Hadler S, Hinman A
Source: Vaccine, December 1998, Vol. 16(20):1917-1922
Measles, Mumps, and Rubella -- Vaccine Use and Strategies for Elimination of Measles, Rubella, and Congenital Rubella Syndrome and Control of Mumps: Recommendations of the Advisory Committee on Immunization Practices (ACIP)
Source: MMWR, May 22, 1998, Vol. 47(RR-8):1-57
No Evidence for Measles, Mumps, and Rubella Vaccine-Associated Inflammatory Bowel Disease or Autism in a 14-Year Prospective Study
Authors: Peltola H, Patja A, Leinikki P, Valle M, Davidkin I, Paunio M
Source: The Lancet, May 2, 1998, Vol. 35:1327-8
Measles Eradication: Experience in the Americas
Authors: de Quadros CA, Hersh BS, Nogueira AC, Carrasco PA, da Silveira CM
Source: Bulletin of the World Health Organization, 1998, Vol 96(Supplement 2):47-52
Immunization of Health-Care Workers: Recommendations of the Advisory Committee on Immunization Practices (ACIP) and the Hospital Infection Control Practices Advisory Committee (HICPAC)
Source: MMWR, December 26, 1997, Vol. 46(RR-18):1-42
Immunization of Adolescents: Recommendations of the Advisory Committee on Immunization Practices, the American Academy of Pediatrics, the American Academy of Family Physicians, and the American Medical Association
Source: MMWR, November 22, 1996, Vol. 45(RR-13):1-16
back to top
Recent Measles Articles
Measles journal articles 2007-2004
This page was updated on February 24, 2016.
This page was reviewed on February 22, 2016.
Immunization Action Coalition  •  2550 University Avenue West  •  Suite 415 North  •  Saint Paul, Minnesota  •  55114
tel 651-647-9009  •  fax 651-647-9131
This website is supported in part by a cooperative agreement from the National Center for Immunization and Respiratory Diseases (Grant No. 6NH23IP22550) at the Centers for Disease Control and Prevention (CDC) in Atlanta, GA. The website content is the sole responsibility of IAC and does not necessarily represent the official views of CDC.